Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Mar-23 9:28 AM View:  | Guinan Mark Director | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 3,673 | -- | -- | (100%) 3.67K to 0 | |
| 10-Mar-23 9:31 AM View: | Mehra Uneek Principal Financial Officer | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 202,696 | -- | -- | (100%) 202.7K to 0 | |
| 10-Mar-23 9:29 AM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 354,303 | -- | -- | (100%) 354.3K to 0 | |
| 10-Mar-23 9:30 AM View: | Marek David C Principal Executive Officer Director | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 417,599 | -- | -- | (100%) 417.6K to 0 | |
| 10-Mar-23 9:32 AM View: | Valente Nancy Director | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 3,673 | -- | -- | (100%) 3.67K to 0 | |
| 10-Mar-23 9:27 AM View: | Curran Terrie Director | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 3,673 | -- | -- | (100%) 3.67K to 0 | |
| 10-Mar-23 9:31 AM View: | Merendino Lauren Chief Commercial Officer | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 169,538 | -- | -- | (100%) 169.54K to 0 | |
| 10-Mar-23 9:32 AM View: | Potter Myrtle S Director | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 3,673 | -- | -- | (100%) 3.67K to 0 | |
| 10-Mar-23 9:28 AM View: | Gulfo Adele M. Director | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 3,673 | -- | -- | (100%) 3.67K to 0 | |
| 10-Mar-23 9:24 AM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 246,684 | -- | -- | (100%) 246.68K to 0 | |
| 06-Mar-23 6:15 AM View: | Sumitomo Chemical Co., Ltd. 10% Owner | Myovant Sciences Ltd. (MYOV) | 03-Mar-23 | Disposition (other) | 4,243,000 | -- | -- | (8%) 50.04M to 45.8M | |
| 20-Jan-23 4:34 PM View: | Merendino Lauren Chief Commercial Officer | Myovant Sciences Ltd. (MYOV) | 18-Jan-23 | Private Sale | 2,008 | $26.89 | $53,995.10 | (1%) 171.55K to 169.54K | |
| 20-Jan-23 4:31 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 18-Jan-23 | Private Sale | 1,109 | $26.89 | $29,821.00 | (< 1%) 247.79K to 246.68K | |
| 20-Jan-23 4:34 PM View: | Marek David C Principal Executive Officer Director | Myovant Sciences Ltd. (MYOV) | 18-Jan-23 | Private Sale | 8,037 | $26.89 | $216,115.00 | (2%) 425.64K to 417.6K | |
| 20-Jan-23 4:36 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 18-Jan-23 | Private Sale | 1,272 | $26.89 | $34,204.10 | (< 1%) 355.57K to 354.3K | |
| 05-Jan-23 5:21 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 04-Jan-23 | Private Sale | 2,251 | $26.90 | $60,551.90 | (< 1%) 250.04K to 247.79K | |
| 05-Jan-23 5:20 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 04-Jan-23 | Private Sale | 2,779 | $26.90 | $74,755.10 | (< 1%) 358.35K to 355.57K | |
| 20-Dec-22 8:07 PM View: | Mehra Uneek Principal Financial Officer | Myovant Sciences Ltd. (MYOV) | 16-Dec-22 | Private Sale | 2,241 | $26.75 | $59,946.80 | (1%) 204.94K to 202.7K | |
| 28-Oct-22 4:34 PM View: | Valente Nancy Director | Myovant Sciences Ltd. (MYOV) | 26-Oct-22 | Grant | 9,859 | -- | -- | 100% 0 to 9.86K | |
| 28-Oct-22 4:45 PM View: | Curran Terrie Director | Myovant Sciences Ltd. (MYOV) | 26-Oct-22 | Grant | 9,859 | -- | -- | 100% 0 to 9.86K | |
| 28-Oct-22 4:36 PM View: | Potter Myrtle S Director | Myovant Sciences Ltd. (MYOV) | 26-Oct-22 | Grant | 9,859 | -- | -- | 100% 0 to 9.86K | |
| 28-Oct-22 4:38 PM View: | Gulfo Adele M. Director | Myovant Sciences Ltd. (MYOV) | 26-Oct-22 | Grant | 9,859 | -- | -- | 100% 0 to 9.86K | |
| 28-Oct-22 4:41 PM View: | Guinan Mark Director | Myovant Sciences Ltd. (MYOV) | 26-Oct-22 | Grant | 9,859 | -- | -- | 100% 0 to 9.86K | |
| 20-Oct-22 4:51 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 18-Oct-22 | Private Sale | 1,933 | $25.20 | $48,711.60 | (< 1%) 360.29K to 358.35K | |
| 20-Oct-22 4:53 PM View: | Marek David C Principal Executive Officer Director | Myovant Sciences Ltd. (MYOV) | 18-Oct-22 | Private Sale | 11,156 | $25.20 | $281,131.00 | (3%) 436.79K to 425.64K | |
| 20-Oct-22 4:54 PM View: | Merendino Lauren Chief Commercial Officer | Myovant Sciences Ltd. (MYOV) | 18-Oct-22 | Private Sale | 1,703 | $25.20 | $42,915.60 | (< 1%) 173.25K to 171.55K | |
| 20-Oct-22 4:50 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 18-Oct-22 | Private Sale | 1,604 | $25.20 | $40,420.80 | (< 1%) 251.65K to 250.04K | |
| 06-Oct-22 4:28 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 04-Oct-22 | Private Sale | 2,738 | $24.40 | $66,807.20 | (1%) 254.39K to 251.65K | |
| 06-Oct-22 4:26 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 04-Oct-22 | Private Sale | 3,679 | $24.40 | $89,767.60 | (1%) 363.97K to 360.29K | |
| 20-Sep-22 4:56 PM View: | Mehra Uneek Principal Financial Officer | Myovant Sciences Ltd. (MYOV) | 16-Sep-22 | Private Sale | 9,243 | $18.86 | $174,323.00 | (4%) 214.18K to 204.94K | |
| 16-Aug-22 5:01 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 15-Aug-22 | Sale | 31,214 | $18.23 | $569,031.00 | (8%) 395.18K to 363.97K | |
| 16-Aug-22 5:01 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 12-Aug-22 | Grant | 124,780 | -- | -- | 46% 270.4K to 395.18K | |
| 20-Jul-22 4:38 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 18-Jul-22 | Market Sale | 1,935 | $12.87 | $24,903.40 | (< 1%) 272.33K to 270.4K | (12%) |
| 20-Jul-22 4:35 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 18-Jul-22 | Market Sale | 1,606 | $12.87 | $20,669.20 | (< 1%) 255.99K to 254.39K | (12%) |
| 20-Jul-22 4:37 PM View: | Merendino Lauren Chief Commercial Officer | Myovant Sciences Ltd. (MYOV) | 18-Jul-22 | Market Sale | 1,704 | $12.87 | $21,930.50 | (< 1%) 174.95K to 173.25K | (12%) |
| 20-Jul-22 4:36 PM View: | Marek David C Principal Executive Officer Director | Myovant Sciences Ltd. (MYOV) | 18-Jul-22 | Market Sale | 11,164 | $12.87 | $143,681.00 | (2%) 447.96K to 436.79K | (12%) |
| 08-Jul-22 4:08 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 06-Jul-22 | Market Sale | 3,702 | $13.40 | $49,606.80 | (1%) 276.04K to 272.33K | (7%) |
| 08-Jul-22 4:09 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 06-Jul-22 | Market Sale | 2,755 | $13.40 | $36,917.00 | (1%) 258.75K to 255.99K | (7%) |
| 01-Jun-22 4:20 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 27-May-22 | Sale | 1,382 | $10.07 | $13,916.70 | (< 1%) 260.13K to 258.75K | |
| 21-Apr-22 4:25 PM View: | Merendino Lauren Chief Commercial Officer | Myovant Sciences Ltd. (MYOV) | 19-Apr-22 | Sale | 7,049 | $10.45 | $73,662.00 | (4%) 182.0K to 174.95K | |
| 21-Apr-22 4:27 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 19-Apr-22 | Sale | 4,632 | $10.45 | $48,404.40 | (2%) 264.76K to 260.13K | |
| 21-Apr-22 4:28 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 19-Apr-22 | Sale | 8,002 | $10.45 | $83,620.90 | (3%) 284.04K to 276.04K | |
| 21-Apr-22 4:25 PM View: | Marek David C Principal Executive Officer Director | Myovant Sciences Ltd. (MYOV) | 19-Apr-22 | Sale | 24,594 | $10.45 | $257,007.00 | (5%) 472.55K to 447.96K | |
| 19-Apr-22 4:48 PM View: | Merendino Lauren Chief Commercial Officer | Myovant Sciences Ltd. (MYOV) | 15-Apr-22 | Grant | 103,703 | -- | -- | 132% 78.3K to 182.0K | |
| 19-Apr-22 4:46 PM View: | Marek David C Principal Executive Officer Director | Myovant Sciences Ltd. (MYOV) | 15-Apr-22 | Grant | 134,567 | -- | -- | 40% 337.98K to 472.55K | |
| 19-Apr-22 4:51 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 15-Apr-22 | Grant | 103,703 | -- | -- | 64% 161.06K to 264.76K | |
| 19-Apr-22 4:52 PM View: | Mehra Uneek Principal Financial Officer | Myovant Sciences Ltd. (MYOV) | 15-Apr-22 | Grant | 111,111 | -- | -- | 108% 103.07K to 214.18K | |
| 19-Apr-22 4:49 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 15-Apr-22 | Grant | 111,111 | -- | -- | 64% 172.93K to 284.04K | |
| 07-Apr-22 4:19 PM View: | Lang Matthew General Counsel & Corp. Secy. | Myovant Sciences Ltd. (MYOV) | 05-Apr-22 | Market Sale | 2,436 | $13.78 | $33,568.10 | (1%) 175.36K to 172.93K | (4%) |
| 07-Apr-22 4:16 PM View: | Ferreira Juan Camilo Arjona Chief Medical Officer | Myovant Sciences Ltd. (MYOV) | 05-Apr-22 | Market Sale | 1,922 | $13.78 | $26,485.20 | (1%) 162.98K to 161.06K | (4%) |
